Is Hexima Limited (HXL.AX) a Buy, Sell, or Hold?
Hexima Limited
ASX:HXL.AX
$0.013 AUD
$0.0 (8.33%)
- Volume
- 15.8K
- Average Volume
- 589.32K
- Market Capitalization
- $2.17M
- P/E Ratio
- -1.45
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.02
- Year Low
- $0.01
- Payout Ratio
- $0.00
- Current Ratio
- $9.12
Industry, Sector & symbol
| Stock Exchange | Australian Securities Exchange |
| CEO | Mr. Geoffrey Paul Kempler B.Sc. |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | HXL.AX |
| CUSIP | None |
| CIK | None |
| Web | https://www.hexima.com.au |
| Phone | 61 3 9479 1210 |
| Currency | AUD |
| Employees | None |
| Country | AU |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 9.12 |
| Quick Ratio | 9.12 |
| Cash Ratio | 8.95 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 17.00 |
| Cash Flow | 0.00 |
| Price / Cash Flow | -3.49 |
| Price / Book | 1.07 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.0056 |
| Trailing P/E Ratio | -1.45 |
| PEG Ratio | -0.01 |
| P/E Growth | -0.01 |
| Net Income | $-933.87K |
| Net Margin | -1169.86% |
| Pretax Margin | -1241.35% |
| Return on Equity | -51.21% |
| Return on Assets | -65.87% |
Financials Score
| AltmanZ Score | -46.62 |
| Piotroski Score | 2.00 |
| Working Capital | 2.02M |
| Total Assets | 2.27M |
| Ebit | -1.66M |
| Market Cap | 2.17M |
| Total Liabilities | 248.67K |
Poll Results
About Hexima Limited (ASX:HXL.AX) Stock
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia. ...
Frequently Asked Questions
-
What is the current Hexima Limited (HXL.AX) stock price?
-
Hexima Limited(ASX:HXL.AX) stock price is $0.013 in the last trading session. During the trading session, HXL.AX stock reached the peak price of $0.023 while $0.008 was the lowest point it dropped to. The percentage change in HXL.AX stock occurred in the recent session was 8.33% while the dollar amount for the price change in HXL.AX stock was $0.0.
-
HXL.AX's industry and sector of operation?
-
The ASX listed HXL.AX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of HXL.AX?
-
Ms. Helen Molloy | Financial Controller
Dr. Neil Forrester | Vice President of Business Development
Dr. Nancy Sacco Ph.D. | Chief Development Officer
Mr. Geoffrey Paul Kempler B.Sc. | MD & Chairman
Prof. Marilyn A. Anderson A.O., AO, B.Sc., BSc (Hons), FAA, FAICD, FT | Chief Science Officer -
How many employees does HXL.AX have?
-
Number of HXL.AX employees currently stands at None. HXL.AX operates from Corporate One, Preston, VIC 3072, AU.
-
Link for HXL.AX official website?
-
Official Website of HXL.AX is: https://www.hexima.com.au
-
How do I contact HXL.AX?
-
HXL.AX could be contacted at phone #61 3 9479 1210 and can also be accessed through its website. HXL.AX operates from Corporate One, Preston, VIC 3072, AU.
-
How many shares of HXL.AX are traded daily?
-
The average number of HXL.AX shares traded daily for last 3 months was 589.32K.
-
What is the market cap of HXL.AX currently?
-
The market value of HXL.AX currently stands at $2.17M with its latest stock price at $0.013